# Promoting Immunotherapy Efficacy With Low-Dose Liver RT

> **NCT07225036** · NA · RECRUITING · sponsor: **Jordan Kharofa** · enrollment: 21 (estimated)

## Conditions studied

- Low-Dose Liver Radiation (LD-LRT)
- Non Small Cell Lung Cancer
- Melanoma
- Liver Metastases

## Interventions

- **RADIATION:** LD-LRT

## Key facts

- **NCT ID:** NCT07225036
- **Lead sponsor:** Jordan Kharofa
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2027-06-15
- **Final completion:** 2029-12-15
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225036, "Promoting Immunotherapy Efficacy With Low-Dose Liver RT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07225036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*